SAM
IMVT icon

Smartleaf Asset Management’s Immunovant IMVT Stock Holding History

Smartleaf Asset Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.31K Buy
183
+7
+4% +$181 ﹤0.01% 2723
2025
Q4 		$4.46K Buy
176
+6
+4% +$134 ﹤0.01% 2754
2025
Q3 		$2.73K Buy
170
+137
+415% +$2.22K ﹤0.01% 2529
2025
Q2 		$531 Sell
33
-144
-81% -$2.18K ﹤0.01% 2576
2025
Q1 		$3.25K Sell
177
-206
-54% -$4.31K ﹤0.01% 2345
2024
Q4 		$9.15K Buy
383
+263
+219% +$7.46K ﹤0.01% 2027
2024
Q3 		$3.36K Buy
120
+7
+6% +$206 ﹤0.01% 2296
2024
Q2 		$2.94K Buy
+113
New +$3.21K ﹤0.01% 2065

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return